Articles

The Changing Face of Site Feasibility

Clinical Research

The Changing Face of Site Feasibility

In the following article by the Journal for Clinical Studies, Travis Caudill writes how the shift from large-scale, global clinical trials to focused orphan indication studies is impacting site feasibility.

On-Demand Webinars

[On-Demand Webinar] Biosimilars: Death or Financial Burden?

Biosimilars

With so many regulations and so much confusion around biosimilars, it can often feel like patients have to choose between death or financial burden. Work with a CRO that can help you achieve the best biosimilar development program. Watch our latest webinar now to learn more.

Articles

Worldwide Clinical Trials Uses AI with Oncology, Rare Disease Precision

Clinical Research, Oncology

Worldwide Clinical Trials Uses AI with Oncology, Rare Disease Precision

In the following article by North Carolina Biotechnology Center, Dr. Elizabeth Witherspoon, NCBiotech Writer, discusses the strategic partnership between Worldwide and Deep Lens to utilize AI technology and develop a greater oncology focus in order to address rapidly changing trial needs.